» Authors » Veronica Ravasio

Veronica Ravasio

Explore the profile of Veronica Ravasio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 357
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Falcone M, Tiseo G, Durante-Mangoni E, Ravasio V, Barbaro F, Ursi M, et al.
Antimicrob Agents Chemother . 2018 Jan; 62(4). PMID: 29378721
The objective of this study was to investigate predisposing factors and outcomes of infective endocarditis (IE) caused by non-HACEK Gram-negative bacilli (GNB) in a contemporary multicenter cohort. Patients with IE...
2.
Giuliano S, Guastalegname M, Russo A, Falcone M, Ravasio V, Rizzi M, et al.
Expert Rev Anti Infect Ther . 2017 Sep; 15(9):807-818. PMID: 28903607
Candida Endocarditis (CE) is a deadly disease. It is of paramount importance to assess risk factors for acquisition of both Candida native (NVE) and prosthetic (PVE) valve endocarditis and relate...
3.
Durante-Mangoni E, Pafundi P, Ravasio V, Barbaro F, Bassetti M, Chinello P, et al.
Infection . 2016 Jan; 44(4):467-74. PMID: 26780903
Purpose: Persons on hemodialysis (HD) are at high risk of infective endocarditis (IE). In non-comparative retrospective studies, a higher rate of mortality was reported in IE on HD. We assessed...
4.
Bruno R, Cariti G, Nasta P, Capetti A, Ravasio V, Galli M, et al.
Liver Int . 2014 Jul; 35(1):120-9. PMID: 25041136
Background & Aims: Hepatitis C virus (HCV) genotype 3 (G3) is common among HIV/HCV co-infected individuals and associated with moderate sustained virological response (SVR) rates with pegylated interferon (PEG-IFN) plus...
5.
Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, et al.
BMC Infect Dis . 2014 May; 14:230. PMID: 24779617
Background: Embolic events are a major cause of morbidity and mortality in patients with infective endocarditis. We analyzed the database of the prospective cohort study SEI in order to identify...
6.
Ripamonti D, Benatti S, Di Filippo E, Ravasio V, Rizzi M
AIDS . 2014 Apr; 28(7):1077-9. PMID: 24685746
No abstract available.
7.
Carosi G, Bruno R, Cariti G, Nasta P, Gulminetti R, Galli M, et al.
Antivir Ther . 2014 Mar; 19(8):735-45. PMID: 24583976
Background: The Optimized Pegylated interferons Efficacy and anti-Retroviral Approach (OPERA) study aimed to assess the efficacy and safety profile of treatment with pegylated interferons (PEG-IFNs) in interferon-naive patients with chronic...
8.
Lalani T, Chu V, Park L, Cecchi E, Corey G, Durante-Mangoni E, et al.
JAMA Intern Med . 2013 Jul; 173(16):1495-504. PMID: 23857547
Importance: There are limited prospective, controlled data evaluating survival in patients receiving early surgery vs medical therapy for prosthetic valve endocarditis (PVE). Objective: To determine the in-hospital and 1-year mortality...
9.
Pasticci M, Moretti A, Stagni G, Ravasio V, Soavi L, Raglio A, et al.
Ann Clin Microbiol Antimicrob . 2011 Jun; 10:26. PMID: 21658248
Background: There is no clear relationship between in vitro bactericidal activity tests and clinical outcome. We studied bactericidal activity of oxacillin, vancomycin and teicoplanin against Staphylococcus aureus isolates in patients...
10.
Maggiolo F, Roat E, Pinti M, Nasi M, Gibellini L, De Biasi S, et al.
Antivir Ther . 2010 Feb; 15(1):51-9. PMID: 20167991
Background: Antiviral drugs of the category of nucleoside reverse transcriptase inhibitors (NRTIs), largely used for the treatment of HIV infection, can have toxic effects on mitochondria. We performed a cross-sectional...